Triglyceride–glucose waist-to-height ratio improves risk stratification for depressive symptoms: evidence from NHANES

European Archives of Psychiatry and Clinical Neuroscience · Published 2026-05-30 · DOI 10.1007/s00406-026-02213-1

Authors (4)

Xiaowei Liu, Xiaowen Liu, Jing Li, Dandan Zhang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Liu, X., Liu, X., Li, J., et al. (2026). Triglyceride–glucose waist-to-height ratio improves risk stratification for depressive symptoms: evidence from NHANES. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-026-02213-1

Related articles

• Associations between plasma BDNF, VEGF, and EGF and cognition in drug-naïve schizophrenia with and without sleep disturbances · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Esketamine multi-omic biomarker evaluation in major depressive disorder (EMBER-MDD): concept, objectives and methodologies of a non-clinical investigator-initiated study · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Distinct effects of current suicidal symptoms and lifetime suicide attempts on C-reactive protein levels and executive function in young people with major affective disorders · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Stressful life events and lifestyle factors are associated with elevated peripheral TNF-α levels in adults with depression without physical diseases · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Family structure, depressive symptoms, and childhood maltreatment in Chinese adolescents: a mediation analysis · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Machine learning-based integration identifies a 10-gene predictive signature and its classification patterns in schizophrenia · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Major depressive disorder-alcohol use disorder comorbidity: diagnosis, mechanisms and treatment · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Efficacy and EEG-ECG mechanisms of taVNS combined with TEAS for negative symptoms of schizophrenia: a protocol for a 2 × 2 factorial randomized controlled trial · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• Differential burden of five major mental disorders in the United States across the COVID-19 pandemic · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal
• The interplay between mental health, ecological factors, and problematic smartphone use: a network analysis in adolescents with major depressive disorder · European Archives of Psychiatry and Clinical Neuroscience · 2026 · Same journal